Michael Brady September 12, 2019
High-cost specialty drugs, increases in care
costs and declining care utilization will spark a 6.5% hike in employer-sponsored health benefits
costs in 2020, according to a new report Thursday.
Consulting firm Aon said non-communicable
diseases are driving healthcare costs across
the world. Musculoskeletal, cancer, cardiovascular, diabetes and high blood
pressure were the most common health problems in the U.S.
The 6.5% increase is similar to Aon's
projections for 2019. Ultimately, the firm expects that medical cost inflation
will surpass general inflation by 3.8%.
"Employers, insurance carriers and the
medical industry have done a commendable job of moderating cost increases in
recent years, considering the headwinds of an aging population, high drug
prices and rising chronic conditions," said Will Sneden, Aon's U.S. Health
Solutions practice leader.
The growth in U.S. medical costs lags the rest
of the world, which Aon expects to rise 8.0% next year. But the difference is
mostly due to an expansion of benefits and slightly more price inflation
worldwide.
Physical inactivity, obesity, poor nutrition,
aging and excessive alcohol and substance abuse are driving risk factors for
non-communicable diseases in the U.S.
"Many of the risk factors lead to chronic
conditions with long term medical costs that make them difficult to treat and
result in long-term medical cost increases," said Tim Nimmer, Aon's global
chief actuary for health solutions. "As a large portion of our waking
hours are spent on the job, the workplace is a logical place to create a
healthier culture and change behaviors."
Nimmer said that he was surprised that excessive
alcohol and drug use, including opioids, was only
reported as a top risk factor in the U.S.
Cost growth in employer-sponsored plans fits the
broader trend that U.S. healthcare costs have grown
faster than general inflation and gross domestic product for years. People are
paying more money for the same amount of care, which most experts agree is
unsustainable.
Consolidation in the healthcare
industry is likely a key driver of healthcare costs, but there's
little sign of it slowing down.
Health systems continue to purchase medical
groups and employ more physicians, giving them increasing negotiating power
with health plans. Site-neutral payments, abolishing all-or-nothing contracting
and getting rid of capped out-of-network emergency care payments could improve
competition, but face steep opposition from trade groups.
Employers have tried to deal with high
employer-sponsored insurance costs by creating narrow care networks and forcing
employees to pay more of their insurance costs.
And payers have merged to help them counteract
the power of growing providers because private employer-sponsored health plans
are paying
hospitals nearly 2.5 times as much as Medicare for the same care.
But economists argue that plan mergers decrease competition in the insurance
market, give employers fewer choices and raise insurance costs.
The result of all this consolidation is that healthcare prices are growing
faster than incomes and the economy, contributing to calls for an
overhaul of the U.S. healthcare system.
No comments:
Post a Comment